Global Bioenergies SA

EPA:ALGBE.PA

1.032 (EUR) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q22011 Q42011 Q22010 Q42010 Q22009 Q4
Revenue 0.0220.3390.1473.1020.5540.1440.0680.0330.0340.030.030.0870.660.0320.180.1260.4190.1170.6540.7090.7091.0840.5860.5720.1420.1420.142000
Cost of Revenue 2.6466.4910.2516.4965.8714.9358.388.8027.6128.4488.3538.8250.420.4130.7890.5230.4560.6080.430.7340.6230.7370.5260.5121.1711.1711.1710.2980.4050.202
Gross Profit -2.624-6.152-0.104-3.394-5.317-4.791-8.311-8.77-7.578-8.417-8.323-8.7370.24-0.381-0.609-0.397-0.037-0.4910.225-0.0250.0860.3470.060.06-1.029-1.029-1.029-0.298-0.405-0.202
Gross Profit Ratio -119.642-18.147-0.703-1.094-9.605-33.286-121.974-267.413-225.59-278.239-275.13-100.1780.364-11.986-3.376-3.151-0.087-4.1970.343-0.0350.1210.320.1020.105-7.272-7.272-7.272000
Reseach & Development Expenses 000.1540.1920.1580.1850.2640.4160.3440.5850.5530.6810.6920.6940.5211.2980.4491.3820.6731.2241.80501.4110000000
General & Administrative Expenses 001.5891.3681.1981.0615.2650000000000000001.7050000000
Selling & Marketing Expenses 000.0840.0640.1030.2021.287000000000000000-1.6240000000
SG&A 1.0911.474.8641.4321.3011.2646.5520.0940.0880.130.120.1256.8846.7538.9045.2527.7795.7386.2465.5834.8864.3063.6892.9680.127000.0290.0570.028
Other Expenses -0.0940-1.139-0.151-0.891-0.2843.846-0.019-0.0040.09-0.067-0.02300000000000000.9460.946000
Operating Expenses 1.1861.475.5771.5832.1921.548-3.8460.1130.0930.040.1870.1487.3698.1038.9685.5715.2436.2176.4855.8464.5814.1862.3393.0340.1270.9460.9460.0290.0570.028
Operating Income -3.81-7.622-5.773-4.977-7.509-6.338-4.465-8.883-7.671-8.458-8.511-8.885-7.112-8.564-9.695-5.939-5.252-6.672-6.162-5.851-4.419-3.897-2.277-2.98-1.956-1.954-1.954-0.494-0.784-0.392
Operating Income Ratio -173.696-22.484-39.185-1.605-13.564-44.04-65.528-270.866-228.346-279.569-281.323-101.869-10.772-269.369-53.768-47.135-12.525-57.026-9.415-8.252-6.233-3.595-3.886-5.21-13.823-13.806-13.806000
Total Other Income Expenses Net -0.5134.8330.0140.893-0.0560.58-1.3941.2621.195-0.0611.942-0.034-0.264-0.243-0.387-0.232-0.426-0.038-0.349-0.0180.0250.1591.490.04600.0190.019-0.00400
Income Before Tax -4.323-2.789-5.759-4.084-7.675-5.759-5.86-7.621-6.476-6.937-6.568-7.58-7.376-8.807-10.081-6.171-5.679-6.824-6.511-5.869-4.394-3.738-2.198-2.934-1.956-1.956-1.956-0.498-0.784-0.392
Income Before Tax Ratio -197.092-8.228-39.091-1.317-13.864-40.011-85.992-232.389-192.759-229.299-217.115-86.912-11.171-277.014-55.913-48.976-13.544-58.325-9.948-8.278-6.197-3.448-3.751-5.129-13.823-13.823-13.823000
Income Tax Expense -1.2517.4271.1870-1.4470-1.7080-2.2640-1.40702.54601.99901.89601.98501.8760-0.4690-0.204-0.204-0.204-0.103-0.135-0.067
Net Income -3.072-2.789-4.572-4.084-6.228-5.759-4.152-7.621-4.211-6.937-5.161-7.58-4.83-8.807-8.082-6.171-3.783-6.824-4.526-5.869-2.518-3.738-2.198-2.934-1.753-1.753-1.753-0.396-0.65-0.325
Net Income Ratio -140.046-8.227-31.034-1.317-11.249-40.011-60.933-232.389-125.362-229.299-170.596-86.912-7.315-277.014-44.825-48.976-9.022-58.325-6.915-8.278-3.551-3.448-3.751-5.129-12.385-12.385-12.385000
EPS -0.17-0.15-0.25-0.23-0.41-0.38-0.28-0.68-0.41-0.78-0.58-0.86-0.86-1.95-1.52-1.68-1.07-2.15-1.57-2.11-0.9-1.36-0.790-1.06-1-1-0.24-13.74-6.87
EPS Diluted -0.17-0.15-0.25-0.23-0.41-0.38-0.28-0.68-0.41-0.78-0.58-0.86-0.86-1.95-1.52-1.68-1.07-2.15-1.57-2.11-0.9-1.36-0.790-1.06-1-1-0.24-13.74-6.87
EBITDA -3.899-0.75-5.045-3.338-7.276-5.523-4.574-6.493-4.477-5.3-4.732-5.573-5.448-6.601-7.068-5.708-4.417-6.294-5.368-5.666-4.265-3.789-2.225-2.921-1.913-1.931-1.931-0.483-0.775-0.387
EBITDA Ratio -177.747-2.214-34.246-1.076-13.143-38.377-67.128-197.991-133.271-175.185-156.432-63.9-8.252-207.624-39.202-45.302-10.533-53.795-8.202-7.992-6.016-3.495-3.797-5.107-13.516-13.647-13.647000